(WIN Consortium) Published in Nature Medicine, results of WINTHER, the first study pioneered by the WIN Consortium — Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial — shows that RNA profiling together with DNA testing matches more patients with advanced cancer to personalized therapies than DNA profiling for tumor mutations alone.

Original source: https://www.eurekalert.org/pub_releases/2019-04/wc-wtr042519.php